Citation Impact
Citing Papers
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
ZBTB1 is a determinant of lymphoid development
2011 StandoutNobel
Establishment of a malignant, epstein-barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease
1979
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Conceptual Synthesis in Community Ecology
2010 Standout
Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
1992
Evaluation of Cytokeratin 7 as an accurate intracellular marker with which to assess the purity of human placental villous trophoblast cells by flow cytometry
2004 StandoutNobel
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
2002 Standout
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
1993
Concordance for Hodgkin's Disease in Identical Twins Suggesting Genetic Susceptibility to the Young-Adult Form of the Disease
1995
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Meta‐analysis: comparing the efficacy of proton pump inhibitors in short‐term use
2003
Expression, Characterization, and Genomic Structure of Carp JAK1 Kinase Gene
1996
Dendritic Cells Expand Epstein Barr Virus Specific CD8+ T Cell Responses More Efficiently Than EBV Transformed B Cells
2005 StandoutNobel
Maternal Intrauterine Infection, Cytokines, and Brain Damage in the Preterm Newborn
1997 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase
2002
Physiologically significant effects of pH and oxygen tension on granulopoiesis
2000
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
The golden age: gold nanoparticles for biomedicine
2011 Standout
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene
2000 StandoutNobel
IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma
2004
Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
2005
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Immunological properties of engineered nanomaterials
2007
High Expression of the CC Chemokine TARC in Reed-Sternberg Cells
1999
Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO)
2002
Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S
2002
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
2000 Standout
CD30 Contains Two Binding Sites with Different Specificities for Members of the Tumor Necrosis Factor Receptor-associated Factor Family of Signal Transducing Proteins
1996
Enzyme immunoassays using bispecific diabodies
1997 StandoutNobel
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Alternative activation of macrophages
2003 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor
1998 StandoutNobel
Interleukin-6: An Overview
1990 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
REGULATION OF IMMUNE RESPONSES BY TGF-β
1998 Standout
Interleukin-6 and the acute phase response
1990 Standout
Fas transduces activation signals in normal human T lymphocytes.
1993 StandoutNobel
JAKS AND STATS: Biological Implications
1998 Standout
Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen.
1991
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
1995 Standout
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma.
1989
Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.
1992
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Direct experimental evidence for alternative stable states: a review
2005
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody.
1990
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
2006 Standout
Polycythemia vera: myths, mechanisms, and management
2002
Hodgkin's disease derived cell lines HDLM-2 and L-428: Comparison of morphology, immunological and isoenzyme profiles
1986
Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA
1981 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Stochastic Community Assembly: Does It Matter in Microbial Ecology?
2017 Standout
Operations Research in Healthcare: a survey
2010 Standout
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
1994 StandoutScience
Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S
2002
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience
2000
The Myeloid-Cell-Specific c-fesPromoter Is Regulated by Sp1, PU.1, and a Novel Transcription Factor
1996
Works of Diehl being referenced
How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation?
1999
Characteristics of Hodgkin's disease-derived cell lines.
1982
Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
1992
Prognostic parameters in polycythaemia vera rubra. Correlations of clinical and histomorphological features in 60 patients.
1987
Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor.
1988
Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin.
1988
Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
1992
A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis
1998
Effects of Enrichment on Three-Level Food Chains with Omnivory
2000
Clinical efficacy of protease inhibitor based antiretroviral combination therapy--a prospective cohort study.
1999
[Epstein-Barr virus (EBV) in lymphoid cells--a human tumor virus?].
1977